Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Jeuveau
(United States) [Available]Synonyms :
Class :
Anticholinergics and ganglionic blocking agents
Brand Name :
Jeuveau
(United States) [Available]Synonyms :
Class :
Anticholinergics and ganglionic blocking agents
Dosage Forms & Strengths
Injection- powder for reconstitution
100units for single-dose vial
Safety and efficacy not established
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
lansoprazole, amoxicillin, and clarithromycin
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
amoxicillin and clavulanate potassium
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the neuromuscular adverse effect of corticosteroids
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the arrhythmogenic effect of cardiac glycosides
may enhance the arrhythmogenic effect of cardiac glycosides
may enhance the arrhythmogenic effect of cardiac glycosides
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
Acetylcholinesterase Inhibitors: they may increase the neurotoxic effect of antipsychotics
Acetylcholinesterase Inhibitors: they may increase the neurotoxic effect of antipsychotics
Acetylcholinesterase Inhibitors: they may increase the neurotoxic effect of antipsychotics
Acetylcholinesterase Inhibitors: they may increase the neurotoxic effect of antipsychotics
Acetylcholinesterase Inhibitors: they may increase the neurotoxic effect of antipsychotics
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
they decrease the efficacy of anticholinergic agents
they decrease the efficacy of anticholinergic agents
they decrease the efficacy of anticholinergic agents
they decrease the efficacy of anticholinergic agents
they decrease the efficacy of anticholinergic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the therapeutic effect when combined with anticholinergic agents
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may increase the nephrotoxic effect of cephalosporins
neomycin/polymyxin B/bacitracin topical
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
loop Diuretics may reduce the neuromuscular blocking effect of neuromuscular-Blocking Agents.
loop Diuretics may reduce the neuromuscular blocking effect of neuromuscular-Blocking Agents.
loop Diuretics may reduce the neuromuscular blocking effect of neuromuscular-Blocking Agents.
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
amoxicillin and clavulanate potassium
Enhance the neuromuscular effect of NMBAs
lansoprazole, amoxicillin, and clarithromycin
Enhance the neuromuscular effect of NMBAs
bismuth subcitrate, metronidazole and tetracycline
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
bismuth subcitrate, metronidazole and tetracycline
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
may increase the therapeutic effect of antibiotics
may increase the bradycardic effect of beta blockers
may decrease the therapeutic effect of Anticholinergic Agents
may enhance the bradycardic effect of beta blockers
may increase the toxic effect of cholinergic agonists
may decrease the therapeutic effect of anticholinergic agents
may decrease the therapeutic effect of Anticholinergic Agents
may increase the toxic effect of nonsteroidal anti-inflammatory agents
may decrease the therapeutic effect of Anti-cholinergic Agent
may increase the neurotoxic effect of Antipsychotic Agents
may decrease the therapeutic effect of Anticholinergic Agents
acetaminophen/doxylamine/dextromethorphan
may decrease the therapeutic effect of Anticholinergic Agents
May decrease the therapeutic effect when combined
may decrease the therapeutic effect of Anticholinergic Agents
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have a decreased therapeutic effect when combined with anticholinergic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
amifampridine: they may increase the therapeutic effect of acetylcholine inhibitors
dipyridamole: they may increase the therapeutic effect of acetylcholine inhibitors
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
bunazosin (Not available in the United States)
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
alpha-1 blocker: they may increase the therapeutic effect of acetylcholine inhibitors
beta blockers: they may increase the therapeutic effect of acetylcholine inhibitors
succinylcholine: they may increase the therapeutic effect of acetylcholine inhibitors
tofacitinib: they may increase the therapeutic effect of acetylcholine inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
Adverse drug reactions:
Frequency defined
>10%
Headache
1-10%
Eyelid ptosis
Increased white blood cell count
Upper respiratory tract infection
Frequency Not Defined
erythema
Needle-related pain
anxiety
Localized pain
Infection
Inflammation
Tenderness
swelling
Pregnancy warnings:
Breastfeeding warnings:
Pregnancy Categories:
Patient Information Leaflet
Generic Name: PrabotulinumtoxinA
Why do we use PrabotulinumtoxinA?
PrabotulinumtoxinA belongs to the class of anticholinergic agents used temporarily to improve the appearance of moderate to severe glabellar lines.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
